Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05645081

Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

PREDICT-EV; the Association of Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

Status
Recruiting
Phase
Study type
Observational
Enrollment
360 (estimated)
Sponsor
Cwm Taf University Health Board (NHS) · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Annually 100,000 strokes occur, placing stroke as the largest cause of disability in the UK. 90% of strokes are preventable, leading to national focus on programmes including "The National Stroke Programme" to act on preventing, treating, and improving post-stroke care. Importantly, over 25% of ischaemic stroke sufferers have previously had a Transient Ischaemic Attack (TIA), which presents the biggest concern for TIA patients. There are no measures which reliably identify TIA patients most likely to suffer a stroke. Novel biomarkers for predicting stroke are key to addressing this problem. The PREDICT-EV study aims to screen 300 TIA patients and follow them over 12-months. The investigators will determine if a novel biomarker we've identified to increase thrombotic risk (endothelial derived extracellular vesicles) and the resulting increased prothrombin time is associated with patients at highest risk of stroke.

Conditions

Timeline

Start date
2021-10-01
Primary completion
2026-09-01
Completion
2027-09-01
First posted
2022-12-09
Last updated
2024-08-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05645081. Inclusion in this directory is not an endorsement.